References:
1. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and
gustatory dysfunctions as a clinical presentation of mild-to-moderate
forms of the coronavirus disease (COVID-19): a multicenter European
study. Eur Arch Otorhinolaryngol . 2020. doi:
10.1007/s00405-020-05965-1.
2. Hopkins C, Surda P, Kumar N.
Presentation of new
onset anosmia during the COVID-19 pandemic. Rhinology . 2020.
doi: 10.4193/Rhin20.116.
3. Lechien JR, Chiesa-Estomba CM, Place S, et al (in press). Clinical
and Epidemiological Characteristics of 1,420 European Patients with
mild-to-moderate Coronavirus Disease 2019. In press, J Int Med .
2020
4. Kaye R, Chang DW, Kazahaya K, Brereton J, Denneny III JC. COVID-19
Anosmia Reporting Tool: Initial Findings. Accepted for publication inOtolaryngol Head Neck Surg . 2020.
5. Beltrán-Corbellini Á,
Chico-García
JL,
Martínez-Poles
J, et al. Acute-onset smell and taste disorders in the context of
Covid-19: a pilot multicenter PCR-based case-control study. Eur J
Neurol . 2020 Apr 22. doi: 10.1111/ene.14273
6.
Yan
CH,
Faraji
F,
Prajapati
DP,
Ostrander
BT,
DeConde
AS. Self-reported olfactory loss associates with outpatient clinical
course in Covid-19. Int Forum Allergy Rhinol. 2020 Apr 24. doi:
10.1002/alr.22592.
7. Moein ST, Hashemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P,
Doty RL. Smell
dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol .
2020. doi: 10.1002/alr.22587.
8. World Health Organization. Clinical management of severe acute
respiratory infection when novel coronavirus (2019- nCoV) infection is
suspected: interim guidance. January 28, 2020
https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf
9. de Dorlodot C, Horoi M, Lefebvre P, Collet S, Bertrand B, Eloy
P, Poirrier AL. French adaptation and validation of the sino-nasal
outcome test-22: a prospective cohort study on quality of life among 422
subjects. Clin Otolaryngol . 2015; 40(1):29-35. doi:
10.1111/coa.12315.
10. Piccirillo JF, Merritt MG Jr, Richards ML.
Psychometric and
clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20).Otolaryngol Head Neck Surg . 2002; 126(1):41-7.
11. Mattos JL, Edwards C, Schlosser RJ, Hyer M, Mace JC, Smith TL, Soler
ZM.
A brief version of
the questionnaire of olfactory disorders in patients with chronic rhinosinusitis.Int Forum Allergy Rhinol . 2019; 9(10):1144-1150. doi:
10.1002/alr.22392.
12. Bhattacharyya N, Kepnes LJ.
Contemporary
assessment of the prevalence of smell and taste problems in adults.Laryngoscope . 2015; 125:1102-6. doi: 10.1002/lary.24999.
13. Hummel, T., Kobal, G., Gudziol, H. et al. Normative data for the
“Sniffin’ Sticks” including tests of odor identification, odor
discrimination, and olfactory thresholds: an upgrade based on a group of
more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007;
264:237–243. https://doi.org/10.1007/s00405-006-0173-0
14. Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia
and ageusia in COVID-19 patients: Single-center experience on 72 cases.Head Neck . 2020. doi: 10.1002/hed.26204.
15. Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, Murakami S.
Identification of
viruses in patients with postviral olfactory dysfunction.Laryngoscope . 2007; 117(2):272-7.
16. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S.
Severe acute
respiratory syndrome coronavirus infection causes neuronal death in the
absence of encephalitis in mice transgenic for human ACE2. J
Virol. 2008; 82:7264-75.
17. Li YC, Bai WZ, Hashikawa T.
The neuroinvasive
potential of SARS-CoV2 may play a role in the respiratory failure
of COVID-19patients. J Med Virol . 2020. doi: 10.1002/jmv.25728.